Proximal Deception: The Convergent Anomaly of ACE-2-Critical Residue Q498
SARS-CoV-2's spike protein residue Q498 links pre-pandemic GOF work, post-pandemic binding data, and the only “natural” precursor that fails exactly at this site.
Editor’s Note: This article has been updated to reflect the proper pre-pandemic coronavirus strain spike RBD residue number (484) equivalent of SARS-CoV-2 RBD residue 498.
Summary:
SARS-CoV-2’s ability to infect human cells is controlled by a small set of 14 ACE-2–contacting residues (Ralph Baric’s numbers) in its spike receptor-binding domain (RBD).
Among these, Q498 is the most interaction-dense ACE-2 binding hotspot, anchoring two of ACE-2’s critical residues (D38 and K353) and stabilizing the RBD internally, therefore quickening the infection process.
Computational mutagenesis data (ACS Nano, 2021) confirm that replacing Q498 leads to one of the largest documented collapses in ACE-2 binding affinity for any RBD residue, confirming its paramount importance.
Significantly, Baric’s own lab carried out mutagenesis experiments at the equivalent residue position in pre-pandemic coronavirus strains.
Despite this, Baric’s March 2020 Journal of Virology analysis quietly confirmed Q498 did make contact with human ACE-2 receptors, but it omitted mention of Q498 from a “critical residues” list and, remarkably, failed to mention the residue even one time in the study text.
Nature’s ‘Proximal Origin’ (March 2020) argued for a natural origin by citing Baric’s 2020 analysis for its own list of ACE-2-critical residues—and did exactly what Baric’s March 2020 analysis did: quietly place Q498 inside of a technical graphic at an inconspicuous location, quietly confirming its significance while hiding it in plain sight.
Another anomaly: BANAL-52, the closest known SARS-CoV-2–like spike backbone, is identical to SARS-CoV-2 at 13 of Baric’s 14 ACE-2-contact residues—the only mismatch is at 498, where BANAL-52 carries histidine instead of glutamine.
This creates a unique convergence:
Baric’s pre-pandemic GOF work focused on the Q498 equivalent (484) in pre-pandemic Urbani strains.
Q498 is one of the most structurally critical SARS-CoV-2 ACE-2-binding hotspots (see ACS Nano, 2021 supplementary material).
BANAL-52 fails only at this position while matching everywhere else.
A second anomaly: Baric’s 2018 engineered coronavirus (CRG7) introduced a “unique” 7-nt motif (UGGUCGC) not found in nature—a motif later appearing only in RaTG13, BANAL-52, and SARS-CoV-2.
Unreleased datasets deepen thev discrepancy: A 2017 U.S. Navy–funded virus-sampling expedition in Laos collected coronaviruses from the same cave and bat species tied to BANAL-52, but those sequences remain undisclosed.
Bottom line: Across independent lines of evidence—structural biology, GOF research history, natural-lineage candidates, and unpublished field samples—one residue (Q498) repeatedly emerges as the decisive hotspot for human ACE-2 binding, yet the closest claimed natural precursor lacks it.
If SARS-CoV-2 emerged naturally, why does the closest alleged precursor virus match the SARS-CoV-2 ACE-2 binding interface at every position except the one residue (Q498) that was targeted, mutated, and characterized in pre-pandemic gain-of-function research?
Did Baric and Proximal Origin downplay Q498 because it would point to pre-pandemic experimentation of the one residue that makes SARS-CoV-2’s RBD unique?
The spike protein of the COVID-19 pandemic pathogen SARS-CoV-2 is what attaches to human cells, causing disease.
This is the same spike protein produced in human cells following injection of mRNA COVID-19 vaccines, like those manufactured by Pfizer Inc. and Moderna Inc.
The spike is comprised of a chain of 1,273 amino acid residues.
The section of this 1,273-amino acid residue chain that binds the spike to human cells is called the receptor-binding domain (RBD).
The RBD comprises residues 319–541 of the spike protein.
Within the spike RBD, there are 14 special amino acid residues within what’s called the receptor-binding motif (RBM) that come into direct physical contact with connectors on human cells called ACE-2 receptors.
These 14 residues responsible for humanizing (optimizing human cell receptor interaction) the spike protein are T415, N439, Y449, Y453, L455, F486, N487, Y489, Q493, Q498, T500, N501, G502, Y505.
T stands for the amino acid threonine, N for asparagine, Y for tyrosine, L for leucine, F for phenylalanine, and Q for glutamine.
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities reaching 300,000+ monthly viewers, contact us by clicking below.
Baric Confirms Q498 Is an ‘ACE-2-contacting Residue’
Those same 14 residues were listed by Dr. Ralph Baric of the University of North Carolina at Chapel Hill immediately following the start of the COVID-19 pandemic, in a March 2020 Journal of Virology publication.
Baric’s March 2020 chart (above) specifically identifies spike protein residue Q498 as an “ACE-2-contacting residue.”
Significantly, however, he stops short of identifying the glutamine-possessing Q498 residue as a “critical residue.”
In fact, his entire Journal of Virology paper makes no mention of residue 498 outside of this chart.
This raises questions, as Baric identifies glutamine-possessing residue Q493 as an ACE-2-critical residue “provid[ing] favorable interactions with human ACE2, consistent with 2019-nCoV’s capacity for human cell infection.”
He emphasizes that “493 in 2019-nCoV RBD is a glutamine.”
And that glutamine-containing 493 “is compatible with hot spot 31, suggesting that 2019-nCoV is capable of recognizing human ACE2 and infecting human cells.”
So why didn’t Baric include glutamine-containing 498?
Q498’s ‘Major Role’ in ACE-2 Binding
According to a 2021 ACS Nano computational mutagenesis study, Q498 is one of the spike protein’s principal binding hot spots, explicitly described as “a viral protein/receptor binding hot spot” that “play[s] a major role in shaping the relevant region of the protein/protein binding interface.”
Q498 simultaneously anchors ACE-2 at two of its most important contact points—“Q498 has anchored ACE2 D38 and K353 in two topical intermolecular HBs (2.92 Å and 2.87 Å)”—while also stabilizing the spike internally through additional hydrogen bonds to “N501 (3.02 Å) and Y449 (3.04 Å).”
This makes Q498 the most interaction-dense residue in the ACE-2-binding region, the only one documented to form a multi-node network linking ACE-2’s D38/K353 hotspot to internal RBD residues Y449 and N501 at the same time.
When Q498 is mutated to no longer possess glutamine, the ACS Nano study reports a major loss of binding free energy, with Q498W showing a destabilization of ΔΔG = −4.18 ± 0.11 kcal/mol—one of the largest affinity collapses recorded for any single RBD residue.
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities reaching 300,000+ monthly viewers, contact us by clicking below.
Baric’s Pre-Pandemic Q498-Homolog GOF Experiments & Post-Pandemic Q498 ACE-2 Binding Findings
In a 2007 PNAS study, his own team deliberately mutated this same position—residue 484, the homolog of SARS-CoV-2’s Q498—by engineering a Y484A substitution in the SARS-CoV Urbani spike and expressing the mutant spike in human 293T cells.
This means he directly mutated the very same position in pre-pandemic strains.
Baric reported that altering residue 484 changed how well antibodies could neutralize the virus, directly demonstrating that Baric’s lab understood the functional and immunological significance of this ACE-2-contact position long before the appearance of SARS-CoV-2.
Ralph Baric knew how to mutate the human ACE-2-critical 498 homologous coronavirus receptor-binding motif residue (484) more than a decade before the COVID-19 pandemic.
By engineering this mutation and demonstrating altered neutralization in human cells, Baric was performing reverse-genetics gain-of-function (GOF) research—genetically modifying a key receptor-binding residue to change the virus’s functional properties.
Taken together, these facts raise the following questions:
Why did Baric omit Q498 from the list of “critical residues” in 2020 when he had spent years studying, mutating, and publishing on the exact same structural position (484) in earlier coronaviruses?
Why did Baric emphasize the importance of glutamine at Q493 in 2020, but not disclose that he had previously engineered the homologous position (484) in 2007 using reverse genetics?
Why did Baric not mention in his 2020 pandemic-era analysis that the pre-pandemic literature—including his own—had already identified the Q498-equivalent position as a receptor-binding hotspot?
Did Baric’s prior gain-of-function work on the 484/498 homolog contribute to an understanding of how glutamine at this position would optimize human ACE-2 binding?
Why was the most interaction-dense ACE-2-binding residue in SARS-CoV-2 (Q498) not discussed in Baric’s paper, despite being the same position he had experimentally altered in human cells years earlier?
BANAL-52: A Near-Perfect ACE-2 Match to SARS-CoV-2 Except at the One Residue That Matters Most
Following the emergence of SARS-CoV-2, researchers pointed to a set of Laotian bat coronaviruses—BANAL-20-52, BANAL-20-103, BANAL-20-236—as potential natural relatives.
Among them, BANAL-52 stands out for one extraordinary reason: BANAL-52 differs from the SARS-CoV-2 spike by only 20 amino acids across the entire 1,273-amino-acid spike protein.
That means that, out of more than one thousand amino acids, the total difference between the BANAL-52 spike and the SARS-CoV-2 spike is less than 2%.
Even more striking is where the similarities cluster.
When the comparison is restricted to the 14 ACE-2–contacting residues listed by Baric in March 2020, a pattern emerges that has no documented precedent in coronavirus evolution:
BANAL-52 is identical to SARS-CoV-2 at every ACE-2–contact residue except one—residue 498.
BANAL-52 possesses histidine (H) instead of glutamine at this position.
Only Q498 fails to match.
And Q498 is the most interaction-dense ACE-2-binding hotspot in SARS-CoV-2—the residue that simultaneously anchors ACE-2 at D38 and K353 while stabilizing the RBD internally through hydrogen bonding with Y449 and N501.
It is also the same structural position Baric’s lab had mutated in pre-pandemic gain-of-function work (484).
Put simply: BANAL-52 is a near-perfect structural template for a SARS-CoV-2–like RBM—except for the single residue most essential for human ACE-2 optimization.
This anomaly deepens when examining the timeline.
Although BANAL-52 was published in a September 2021 Nature publication, the samples were said to be collected before 2020.
And evidence indicates that closely related viruses may have been collected in 2017 during a U.S. Navy–funded bat-coronavirus expedition in Laos.
That expedition sampled the same cave, the same bat species (R. malayanus), and the same region where BANAL-52 would later be reported.
The 2017 sequences were never released publicly.
And the official BANAL-52 sequences, collected in 2019–2020, remained undisclosed until late 2021—more than a year into the pandemic.
A second anomaly reinforces this.
In 2018, before the pandemic, Baric published an engineered coronavirus, CRG7, in Nature containing a “unique” seven-nucleotide motif UGGUCGC, not present in any known natural coronavirus.
Yet this same motif later appeared in RaTG13, BANAL-52, and SARS-CoV-2.
And nowhere else.
This means the “unique” motif Baric engineered into CRG7 in 2018 is found only in:
Baric’s own engineered virus (CRG7), and
the exact small set of unpublished coronaviruses later claimed to be the closest relatives of SARS-CoV-2.
Therefore, BANAL-52 reproduces the entire SARS-CoV-2 ACE-2 binding motif and differs from SARS-CoV-2 by only 20 amino acids across the entire spike—yet it fails precisely at RBM residue Q498, the very residue Baric had experimentally manipulated and the residue most critical for human infection.
This leads to the unavoidable question:
Why does the closest known natural virus replicate the SARS-CoV-2 spike almost perfectly—except for the one residue whose humanizing effect was already demonstrated in pre-pandemic gain-of-function work?
Proximal Deception?
The effort to shut down debate over SARS-CoV-2’s origin culminated in March 2020, when Nature Medicine published “The Proximal Origin of SARS-CoV-2.”
The paper immediately became the definitive claim that the virus could not have been engineered.
Yet its central argument rests not on a thorough examination of SARS-CoV-2’s structural features, but on a series of narrowing choices—truncated residue lists, misnumbered positions, selective citations, and carefully crafted graphics—that obscure the very evidence that would contradict its conclusion.
The authors begin by insisting that only six amino acids in the receptor-binding domain determine ACE-2 binding.
They cite Y442, L472, N479, D480, T487, and “Y4911,” making a typographical error by adding an extra “1” at the end of Y491.
Erasing Q498 from view becomes even more conspicuous in Figure 1, the alignment intended to show the distribution of ACE-2-contact residues across SARS-CoV-2, SARS-CoV, RaTG13, pangolin-CoVs, and other SARS-related viruses.
This central graphic in Proximal Origin appears at first glance to present an unbiased multi-species alignment of the spike protein.
But the figure is constructed in a way that removes the functional significance of the residue with the greatest bearing on SARS-CoV-2’s ACE-2 affinity.
The region spanning residues 460 to 500 clearly includes the SARS-CoV-2 position Q498, the residue that completes the humanized receptor-binding interface; the residue corresponding to 484 in pre-pandemic SARS-CoV that Baric experimentally mutated in 2007.
Q498 is visible in the alignment, but it is treated as though it has no relevance at all.
The authors place blue boxes around residues they declare to be the “ACE2 contact residues,” yet Q498 is deliberately excluded from this set, as if it contributes nothing to receptor binding.
A residue central to binding affinity, host-range determination, and the structural “humanization” of the SARS-CoV-2 RBM is treated as though it plays no functional role at all.
The chart is therefore not only incomplete, but is constructed in a way that prevents the reader from recognizing the structural feature at the center of SARS-CoV-2’s binding behavior.
Q498 is present in pixels but absent in meaning.
By excluding it from the highlighted ACE-2-contact set, the figure creates the false impression that the critical determinants of binding reside elsewhere, allowing the authors to suggest that SARS-CoV-2’s RBD shows no sign of laboratory manipulation.
To make things worse, Proximal Origin cites Baric’s 2020 Journal of Virology analysis (mentioned in our introduction) at the end of the sentence that lists the handful of residues.
That analysis from Baric himself clearly characterized 498 as an “ACE2-contacting residue.”
So why would Proximal Origin not simply copy Baric’s own list?
In the end, the structure of the Proximal Origin argument depends on what the authors decline to examine.
The Q498 position is left unmarked and unmentioned, even though Baric himself published its importance in peer review.
The ACE-2-binding residue set is artificially reduced.
The claim that “no laboratory-based scenario is plausible” is sustained not by what the paper proves, but by what it conceals.
Q498—the residue most crucial to the question—is not refuted.
It is simply moved off the page.
Bottom Line
Across independent datasets, one structural irregularity keeps appearing at the exact same position in the spike protein.
Q498 is the residue shown to drive human ACE-2 binding more than any other position in the receptor-binding motif.
It anchors two of ACE-2’s most important contact points and stabilizes the RBD internally.
It is also the position Baric’s group altered through reverse genetics years before the pandemic.
Every major line of evidence points toward Q498 as the decisive site for human adaptation—except the one sequence that would need to contain it if SARS-CoV-2 emerged through a natural spillover.
BANAL-52 matches SARS-CoV-2 at virtually the entire ACE-2 contact interface.
Across Baric’s 14 ACE-2-contact residues, 13 align perfectly.
The lone mismatch is Q498, replaced in BANAL-52 with histidine (H).
That single residue is the difference between a virus optimized for human ACE-2 and a virus that fails at the strongest hotspot for human binding.
The rest of the interface is already in place.
Additional threads tighten the pattern:
The 2017 U.S. Navy–funded Laos expedition sampled the same cave and the same bat species later associated with BANAL-52, yet those sequences remain unreleased.
The “unique” CRG7 motif engineered by Baric in 2018 appears only in his engineered strain and in the handful of coronaviruses later presented as the nearest relatives of SARS-CoV-2.
Proximal Origin minimized the ACE-2 interface to six residues—concealing Q498’s significance—and built graphics that visually remove this position’s functional importance.
The recurring alignment on this single site raises questions that demand transparent answers:
Why does the only close SARS-CoV-2–like backbone disclosed to date fail precisely at the one residue with outsized impact on human ACE-2 binding?
Why was this same glutamine-possessing residue altered in pre-pandemic gain-of-function work, yet absent from Baric’s list of “critical residues” in 2020?
Why did Proximal Origin exclude Q498 from its highlighted ACE-2 contact set despite citing Baric’s own work that acknowledges the residue binds to human cells?
How did the CRG7 motif appear in the same small cluster of viruses tied to SARS-CoV-2’s supposed natural lineage?
Have any Laos samples, particularly from 2017, been withheld or used in unpublished experiments?
For scientists, lawmakers, and citizens, the issue comes down to a basic factual conflict: the strongest human-binding hotspot in SARS-CoV-2 is the only hotspot missing from the virus claimed to be its natural progenitor—and the same hotspot that appears repeatedly in the history of laboratory manipulation.
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities reaching 300,000+ monthly viewers, contact us by clicking below.
I am happy I found your substack. You are providing tremendously important information and analysis. Admittedly, your article, like many others I've read on the subject of GOF and Covid, is so technical that I can only glean certain aspects. If I tried to explain this to the average person, I would fail miserably. Broadly speaking, if we want more people to understand the depths of the deception, we need a layman's guide alongside the scientific research and talking points. How else to engage our friends and neighbors when all they want to do is forget and move on? We need a way to hammer this home if we ever want to see accountability.
Admittedly that one made my head spin. Thank you! You are a scientific titan! During this holiday season, let’s not forget to thank Baric, Daszak, Zhen and Fauci for giving us the self- replicating spike protein, a gift that keeps on giving. Stay strong friends. We are going to win this💕